Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1379-1392
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Cancer epigenetics: from laboratory studies and clinical trials to precision medicine
Xinyang Yu, Hao Zhao, Ruiqi Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 94
Exploiting RIG-I-like receptor pathway for cancer immunotherapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 74
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 70
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 63
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
Federica Francescangeli, Maria Laura De Angelis, Rachele Rossi, et al.
Cancer and Metastasis Reviews (2023)
Open Access | Times Cited: 43
Type I interferon and cancer
Peter Holíček, Emma Guilbaud, Vanessa Klapp, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 115-127
Open Access | Times Cited: 43
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases
Thomas Kerzel, Giovanna Giacca, Stefano Beretta, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1892-1910.e10
Open Access | Times Cited: 43
Targeting inflammation as cancer therapy
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Circulating tumor cells: from new biological insights to clinical practice
Xuyu Gu, Shiyou Wei, Xin Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Signaling, cancer cell plasticity, and intratumor heterogeneity
Marco Cordani, Ilaria Dando, Giulia Ambrosini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 16
Epigenetic regulation of cancer
Lorenzo Galluzzi, Sheila Spada
International review of cell and molecular biology (2025), pp. xiii-xvii
Closed Access | Times Cited: 2
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
3D cancer models: One step closer to in vitro human studies
Nicoletta Manduca, Ester Maccafeo, Ruggero De Maria, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
Ming Jin, Kwang Won Jeong
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1333-1347
Open Access | Times Cited: 32
Histone demethylases in the regulation of immunity and inflammation
Lihua Qu, Tong Yin, Yijin Zhao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Immunosurveillance encounters cancer metabolism
Yu‐Ming Chuang, Sheue‐Fen Tzeng, Ping‐Chih Ho, et al.
EMBO Reports (2024) Vol. 25, Iss. 2, pp. 471-488
Open Access | Times Cited: 15
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Chen Yang, Haigang Geng, Xupeng Yang, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2064-2081.e19
Closed Access | Times Cited: 12
Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway
Xiaobo Luo, Yan Qiu, Zackary R. Fitzsimonds, et al.
Oncogene (2024) Vol. 43, Iss. 6, pp. 388-394
Closed Access | Times Cited: 10
Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 19-39
Closed Access | Times Cited: 8
The interplay between autophagy and cGAS-STING signaling and its implications for cancer
Maximilian Schmid, Patrick D. Fischer, Magdalena Engl, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top